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Despite the introduction of needle and syringe exchange programs (NSPs), sharing of syringes and
other materials remains common among injection drug users (IDUs) worldwide. For this reason, IDUs
are at high-risk of HIV transmission. This paper studies the psychosocial and psychopathological
determinants of sharing among IDUs. Understanding the relationship between psychological morbidity,
HIV knowledge, HIV risk perception, and sharing behaviors is important to develop campaigns to
curb sharing among IDUs. We recruited 120 male (76.7%) and female (23.3%) IDUs at a public
outpatient treatment service in northern Portugal whose age average was 34 (sd=7.56). They were
characterized for sociodemographic, clinical, and behavioral variables, as well as for knowledge on
HIV transmission and prevention, HIV risk perception, and psychopathological symptoms. Almost all
patients (95.8%) were tested for HIV and 31.7% were HIV positive. Half of them had a chronic disease
(50.8%) and declared to engage in sharing (51.7%). Most had accurate knowledge of HIV transmission
and prevention. A great majority deemed HIV risk to be high in their communities (80.8%) but deemed
their personal risk to be zero or low (72.5%). Statistical analysis showed that sociodemographic
variables (female sex, lower education, living alone) and psychopathological symptoms (obsession-
compulsion and somatization) predict sharing. We conclude that the development and implementation
of campaigns to reduce sharing among IDUs should focus more on women, IDUs living alone, as well
as early assessment and intervention on psychopathological disorders.
Key words: HIV risk injecting behavior, HIV knowledge, HIV risk perception, Psychopathology,
Injection drug users (IDUs), Portugal.
Introduction
There are about 14 million people who inject drugs, while 1.6 million live with HIV/AIDS
worldwide (United Nations Office on Drugs and Crime, 2013). In Europe, about 2.2 million people
were living with HIV in 2012 (World Health Organization, 2013). Joint United Nations Program in
HIV/AIDS (UNAIDS) and WHO estimates are indicative that in that year about 48 000 people in
Portugal were living with HIV (UNAIDS, 2012; WHO, 2013). These cases were associated with
sexual via of transmission in heterosexual couples (63.1%) and homosexual men (24.1%), and in
10% of the new cases the transmission was related with drug use, according with the estimates of
National Health Institute Doutor Ricardo Jorge (INSA, 2013). According with the European
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Monitoring Centre for Drugs and Drug Addition (EMCDDA), in Portugal the prevalence of
infectious diseases among drug users in the year 2011 was 16.5% for HIV, 4.3% for acute Hepatitis
B (HBV) and 79.7% for Hepatitis C (HCV) infection (EMCDDA, 2012).
The association between injecting drug use and HIV exposure seems to result from higher risk
behaviors for HIV, including sharing syringes and other objects used in intravenous drug consumption,
as well as sexual risk behaviors (Degenhardt, Mathers, Vickerman, Rhodes, Latkin, & Hickman,
2010). Through multiple exposure ways to HIV infection, IDUs constitute a high risk group for the
transmission of HIV and other blood borne infectious diseases, representing a major public health
concern and a burden to socio-economic systems (Mathers et al., 2010; Seeman et al., 2011).
Preventive interventions directed to this at-risk group have been a priority in order to control
this epidemic (AIDS Alert, 2010; AIDS Policy Law, 2013; Des Jarlais & Seeman, 2008; Meijerink,
van Crevel, & van der Ven, 2013; Semaan et al., 2011), and in general they include needle and
syringe programmes (NSPs), other drug treatment and/or opioid substitution therapy (OST), anti-
retroviral therapy (ART), HIV serostatus testing and counseling, and promotion of condom use,
according with the reference group from the United Nations (UN) on HIV and IDU (Mathers et
al., 2010). Adopting the European strategy, the 2005-2012 Portuguese National Plan Against Drugs
and Drug Addiction (Diário da República, Law of the Portuguese Republic, 2006; vide Resolution
of the Council of Ministers nr 115/2006, 18th September), is a sign of an integrative systemic view
of interventions, including individual and socio-structural factors.
Scientific evidence reports that NSPs may reduce risks associated with injecting drugs, like
infectious diseases and mortality (Aspinall et al., 2013; Semaan et al., 2011). Education about risk
behaviors is generally accepted as an effective way to prevent HIV/AIDS infection (Des Jarlais
& Semaan, 2008) and there is evidence of a significant reduction of risk behaviors associated with
syringe sharing among high risk IDUs who had a peer education intervention about HIV risk
behaviors (Go et al., 2013; Mackesy-Amiti et al., 2013). Other authors argue that education alone
is not sufficient in reducing risk among IDUs (Madray & van Hulst, 2000), because HIV
transmission among IDUs still happens, and also because risk taking behaviors among IDUs in
some studies were not influenced by knowledge about HIV transmission and prevention,
educational status or history of HIV testing or serostatus (Sarkar et al., 1995).
HIV risk perception is a core element of prevailing health behavior theories such as the “Health
Action Process Approach” (HAPA) (Schwarzer, 1999) and the “Health Belief Model” (Janz & Becker,
1984). Theoretically, higher HIV risk perception should make individuals adopt precaution measures.
In fact, one common strategy used in HIV prevention interventions is raising awareness of risk (Crisp
et al., 1993). Essien and col. (2008) found a statistically significant decrease in HIV risk perception
among IDUs compared with non-IDUs. This result suggests an inverse correlation between actual
risk of HIV infection and HIV risk perception. Therefore, targeting HIV risk perception, which is a
significant determinant of behavior change, is essential to reduce the prevalence of HIV infection. In
the study of Tsui, Lau, Xiang, Gu and Wang (2012) with 377 IDUs, the authors assessed risk
perceptions (HIV transmission via unprotected sex and via syringe sharing) and behavioral intention
to adopt protective risk behaviors (condom use and avoid syringe sharing totally), and their results
corroborate the motivational hypothesis that risk perceptions motivate one to adopt protective
behaviors.
Accurate knowledge on HIV/AIDS is a necessary but not a sufficient condition for the consistent
adoption of protective behaviors. If the lack of such information contributes to an increased
vulnerability to HIV/AIDS in many contexts (Goncalez et al., 2010), the lack of correct information
about HIV transmission may contribute to fewer people being tested, to misperceptions about one’s
level of risk, and to increased likelihood of AIDS optimism, denial, and stigmatization, among other
adverse psychosocial influences (Vermeer, Bos, Mbwambo, Kaaya, & Schaalma, 2009). Bertoni and
col. (2011) assessed drug users’ knowledge of HIV/AIDS and its possible association with HIV testing,
and found that drug users had an increased vulnerability to HIV infection compared with the general
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population. Their findings also suggest that possessing inaccurate HIV/AIDS knowledge could be a
barrier to HIV testing. In another study, Zafar, Brahmbhatt, Imam, Ul Hassan and Strathdee (2003)
found that extremely low levels of HIV/AIDS awareness and high HIV risk behaviors were evident
among drug users.
Another pathway of explanation for risk injecting behaviors among IDUs is related with high
morbidity of psychiatric disorders besides drug addiction (Buckley, 2006; Santucci, 2012).
Psychiatric disorders including other substance abuse, major depression disorder, anxiety,
posttraumatic stress disorder, antisocial personality disorder, borderline personality disorder, and
psychosis are commonly found comorbid with drug addiction (Braitstein et al., 2005; Buckley,
2006; Compton, Cottler, Shillington, & Price, 1995; Disney et al., 2006; Kirdorf et al., 2004;
Mackesy-Amiti, Donenberg, & Ouellet, 2012).
Furthermore, some evidence pointed out that among IDUs, those with psychiatric morbidity have
greater HIV risk behaviors (Compton et al., 1995; Disney et al., 2006; Kirdorf et al., 2004). More risk
behaviors for acquiring HIV/AIDS, such as more sharing of syringes and needles in IDUs, were found
among individuals with a history of suicide attempt (Sarin, Singh, Samson, & Sweat, 2013), antisocial
personality disorder (Comptom, Cottler, Ben-Abdallah, Cunningham-Williams, & Spitznagel, 2000;
Disney et al., 2006) and major depression (Disney et al., 2006; Kidorf et al., 2004; Wisniewski et al.,
2005), these higher on women than in men, and more evident on women who inject drugs and are
infected with HIV/AIDS (Wisniewski et al., 2005). Other complications, such as more somatic
complaints, as fatigue symptoms and worse quality of life were also found among IDUs, and even
more in those infected with HIV and HCV (Tavakkoli, Ferrando, Rabkin, Marks, & Talal, 2013).
Social exclusion and discrimination were also common factors associated with HIV infection and
injecting drug behaviors and related with more HIV risk behaviors (March, Oviedo-Joekes, & Romero,
2006, 2007).
This study aims to determine the main predictors of HIV risk injecting behavior in a sample of
IDUs in the northern region of Portugal. Sociodemographic factors, knowledge about HIV
transmission and prevention, HIV risk perception and psychopathological symptoms were the
considered predictors.
Method
Sample
The sample consisted of 120 participants, 92 males and 28 females with an age average of 34
(sd=7.56), ranging between 18 and 56 years old. In terms of marital status, the vast majority of the
participants were single (71.7%), and the rest were divorced (15.8%), married (2.5%) and the
remaining lived in marital union, but were not married (6.7%). Regarding the professional situation,
75.8% were unemployed, 16.7% had a job, 5% were studying and 2.5% were retired. Most of the
participants (67.5%) lived with their parents or relatives, 11.7% with their husband or partner, 5.8%
with friends, 9.2% alone, and 5.8% don’t have a place to live or lived in institutions (e.g., Red Cross).
Regarding the level of education, 3.3% of participants did not have qualifications, 5% had the
1st cycle of studies (4 years), 32.5% had the 2nd cycle (6 years), 35.8% had the 3rd cycle (9 years),
20.8% had secondary education (12 years) and 2.5% higher education (16 years and more). In
terms of consumption, all participants consume or consumed tobacco, 85% alcoholic beverages,
92.5% cocaine, 87.5% heroin, 88.3% hashish, 52.5% LSD, 54.2% amphetamines, 55% tranquilizers
and 54.2% ecstasy. The start age of consumption was, in average, 15 years (sd=3.16) and in mean
its duration was 19 years (sd=6.86).
In terms of clinical and behavioral characterization of the sample, the vast majority of the
participants (95.8%) have been tested for HIV and 31.7% were HIV positive. 19.2% of the HIV
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positive think that they got the virus by sharing material used in drug consumption and 11.7%
think they got it through sexual interaction. In what concerns other diseases, 50.8% of the
participants have a chronic disease, 35.8% have hepatitis C and 11.7% have hepatitis B. With
regard to current consumption, the vast majority of the participants (90%) currently consume
drugs, with most of them currently using intravenous drugs.
Regarding the use of condoms during sexual intercourse, 22.5% of the participants always use
condoms, 62.5% use sometimes and 15% never used condoms in their sexual encounters. Half of
the participants (50%) had an overdose in the past, 32.5% have already been arrested and from
those 8.3% shared materials for consumption while in prison. With regard to sharing material,
51.7% of the participants have shared materials for drug use, 37.7% shared syringes and 37.5%
have shared other materials like bottle caps, cotton and spoons.
Measures and procedure
Study participants were IDUs attending attending an urban clinic of the Portuguese Drug and
Drug Addition Institute in northern Portugal (Centros de Respostas Integradas do Instituto da
Droga e da Toxicodependência). Most patients were referred by the medical staff and after
reporting injecting drugs and other materials. Patients attending medical visits during May and
June 2013 were asked by the medical staff in the clinic if they would participate in a brief interview.
Participants were also informed that the investigators were trying to understand the factors
involved with HIV-risk injecting behavior among drug users in Portugal to improve prevention
efforts. Additionally, they were told that the information shared was confidential. The study was
approved by the Portuguese Drug and Drug Addition Institute Review Board and by its ethics
Board as well as by the Portuguese Catholic University Board. One hundred fifty patients were
approached for interviews and thirty refused to participate.
Participants completed several self-report questionnaires that had been previously adapted and
validated to Portugal. Socio-demographic and clinical features, HIV knowledge, AIDS risk
perception and psychopathological symptoms were assessed. The measures and their psychometric
properties in this sample are described below.
AIDS-related Knowledge was assessed by fourteen questions adapted from the 1988 Public Health
Service AIDS Information Survey (Hobfoll, 2000; Hobfoll et al., 2002; U.S. Public Health Service,
1988, cit. in Hobfoll, Jackson, Lavin, Britton, & Sheperd, 1994) and subsequently translated and
validated into Portuguese (Costa, 2006; Costa & McIntyre, 2002). They assess one’s knowledge of
HIV transmission and prevention, and have been shown to accurately measure safe-sex knowledge
(Hobfoll, Jackson, Lavin, Britton, & Sheperd, 1993). The items have a 3-option response format:
“wrong”, “right” and “don’t know”. The percentage of correct answers was used as summary score
(higher values indicate higher knowledge). The Cronbach α internal consistency reliability for the 14
item scores was high (α=0.89). Eight of these 14 items measure knowledge of HIV transmission and
produced a Cronbach’s α of 0. 82. Six items assess knowledge of how to prevent HIV infection during
sexual activities (Cronbach’s α=0.83).
AIDS risk perceptions. Two items from the Women’s Health Study (Costa, 2006; Hobfoll et al.,
2002; Schroder, Hobfoll, Jackson, & Lavin, 2001, adapted to Portuguese by Costa & McIntyre, 2002)
assessed whether the participants’ heterosexual contacts in general, and their sexual behavior in
particular, placed them at risk of HIV infection, response format being a Likert 4-point scale (1 to 4:
none, low risk, moderate, higher risk). A question asked whether the participants discussed HIV/AIDS
danger and prevention with their partners, response format being a Likert 3-point scale (1 to 3: with
every partner, with some partners, never).
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Psychopathological symptoms. Psychopathological symptoms were assessed with the Brief
Symptom Inventory (BSI) (Derogatis, 1992, Portuguese version translated and adapted by Canavarro,
1995) which includes 53 items and provides nine sub-scale scores measuring a range of psychological
symptoms and somatic complaints. This instrument assesses nine dimensions of psychopathology
along with three global indexes that offer a summary evaluation of emotional disorders and the
participant describes the degree in which each problem has affect him in the last week. The dimensions
assessed were somatization, obsession-compulsion, interpersonal sensitivity, depression, anxiety,
hostility, phobic anxiety, paranoid ideation and psychoticism and higher values indicate higher
psychopathology. Although the General Severity Index (GSI) is the most used measure of the Brief
Symptom Inventory, we used the nine sub-scales to assess the diversity of psychopathological
symptoms because one of our goals is to analyze the psychopathological dimensions that better predict
HIV-risk injecting behavior among drug users. The original scale shows a Cronbach α between .70
and .80. In this study the α value was .96 for the total scale, which shows an excellent internal
consistency and the Cronbach α for each subscale ranges between .70 and .85: somatization (α=.80),
obsession-compulsion (α=.80), interpersonal sensitivity (α=.77), depression (α=.84), anxiety (α=.83),
hostility (α=.85), phobic anxiety (α=.78), paranoid ideation (α=.77) and psychoticism (α=.70).
Statistical analysis
Data were analyzed using the IBM® SPSS® (19.0 version). Internal consistency of responses
to the questionnaires was assessed using Cronbach Alpha. A correlation analysis was conducted
using two-tailed Pearson Correlation Test to study the relation between indicators of HIV sharing
risk behaviors and potential predictor variables, with post-hoc correction test Bonferroni for p
values. With regard to predictors of sharing, we develop a common model of predictors. All
predictors were patronized to solve the problems of collinearity and distribution. For our current
model the VIF values were all well below 10 and the tolerance statistics all well above 0.2;
therefore, we can safely conclude that there is no collinearity within our data. Hierarchical linear
regression analysis (enter method) were conducted to identify significant predictors of syringe
sharing. The social demographic variables were included in the first step, AIDS-related Knowledge
was entered in the second step and psychopathological symptoms were added to the model at last.
Results
In terms of HIV transmission knowledge the results show that most of participants (n=102,
85%) knew that sharing syringes is an effective transmission way, and had correct HIV risk
knowledge about working near someone with HIV (n=91, 75.8%), eating at a restaurant in which
the cooker has HIV (n=76, 63.3%), shaking hands, touch or kiss the face of someone with HIV
(n=82, 68.3%), using public bathrooms (n=71, 59.2%), and being cough or sneezed by someone
with HIV (n=74, 61.7%). In general participants reported accurate information regarding HIV
transmission, nevertheless, incorrect information was found in some individuals that considered
sharing plates, forks or glasses with someone with HIV (n=36, 30%) and risk of infection by
mosquitoes or other insects infected with HIV (n=56, 46.7%) as HIV transmission ways.
In terms of HIV prevention knowledge, most of participants have correct knowledge about the
prevention power of using condoms (n=112, 93.3%), having only one sexual partner without HIV
(n=83, 69.2%) and consider the use of gel, foam or spermicide cream (n=65, 54.2%) as effective
preventive practices. Less accurate information regarding HIV prevention knowledge was found
for abstinence (n=52, 43.3%) and interrupted coitus (n=55, 45.8%).
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With regard to AIDS risk perceptions, almost all participants declared that their community
had some risk, with 16 participants (13.3%) believing that their community has low risk of HIV
infection, 52 (43.3%) believing that their community has moderate risk of HIV infection, and 45
(37.5%) believing that their community has high risk of HIV infection. Only 7 (5.8%) believed
that their community has no risk of HIV infection. In terms of personal risk, the majority of the
participants believed that their behavior doesn’t put them at risk for HIV infection, with 39 (32.5%)
believing being at low risk, 17 (14.2%) believing being at moderate risk, and 16 (13.3%) believing
being at high risk of HIV infection. The remaining 48 participants (40%) believed that their
behavior does not present any risk of HIV infection. With regard to HIV/AIDS communication,
only 33 participants (27.5%) speak with all partners about HIV/AIDS. Most of the sample rarely,
or never, speaks with partners about HIV/AIDS (n=57, 47.5%), or does not speak with all their
partners about it (n=30, 25%).
Correlational results
In order to understand the relationship between the potential predictor variables (socio -
demographic variables, consumption, AIDS-related knowledge, AIDS risk perceptions and
psychopathological symptoms) and general sharing behaviors, syringe sharing behaviors and
sharing behaviors of other materials we performed a Pearson correlation analysis (see Table 1).
Results show that general sharing behavior in the context of drug use occurs more frequently in
women, in participants with low educational level, among those living alone, with early age of
initiation of drug use, and with more psychopathological symptoms in all the BSI scales.
Table 1
Correlations between indicators of sharing behaviors and potential predictor variables
Variable General sharing behavior Syringe sharing Other materials sharing
Gender .297** .387** .305**
Age .016 .099 .058
Civil state -.052 .044 .029
Education -.153* -.380** -.284**
Professional status -.077 -.156* -.184*
People with whom they live .388** .385** .340**
Drug use initiation age -.204* -.073 -.190*
Years of drug use .124 .153* -.159*
General symptoms index .085 .152* .114
Somatization .309** .243** .300**
Obsession-compulsion .292** .246** .170*
Interpersonal sensitivity .177* .139 .187*
Depression .293** .327** .299**
Anxiety .247** .218** .213**
Hostility .210* .158* .123
Phobic anxiety .243** .157* .192*
Paranoid ideation .193* .162* .159*
Psychoticism .237** .204* .213**
HIV transmission knowledge -.110 -.173* -.136
HIV prevention knowledge .005 -.186* -.126
HIV community risk perception -.113 -.121 -.053
HIV personal risk perception .056 .133 .010
Note. ***p<0.001;**p<0.01; *p<0.05.
As we can see on Table 1, syringe sharing behavior in the context of drug use occurs more
among women, in participants with lower education, unemployed, living alone, with a longer time
of drug use, and with more psychopathological symptoms in almost all of the BSI scales (except
interpersonal sensitivity), and lower knowledge about HIV transmission and prevention. Similarly,
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sharing of other materials in drug injection was significantly correlated with gender (females),
participants with low educational level, unemployed, living alone, with chronic and long-term
drug use, and more psychopathological symptoms in almost all of the BSI scales (except hostility).
Predictors of sharing injecting materials
Hierarchical linear regression analyses were conducted to estimate the relationship between
gender, education, professional status, years of consumption, HIV transmission and prevention
knowledge, and psychopathological symptoms as potential predictors of the dependent variable:
(a) general sharing, (b) syringe sharing and (c) other materials sharing.
Regarding general sharing behavior in the context of drug use, the hierarchical linear regression
model with all mentioned predictors explains 31.7% of variance of general sharing behaviors
[R²=.317, F(16,103)=2.98, p<.001]. As can be seen in Table 2, females and individuals who live
alone were those who display more sharing behaviors. Furthermore, 20.8% of the variance of
general sharing is explained only by socio-demographic variables, and the inclusion of knowledge
variables in step 2 (∆R2=.006, p>.05) and of psychopathological symptoms in step 3 (∆R2=.103,
p>.05), don’t improve the model significantly.
Table 2
Hierarchical linear regression for sociodemographic, behavioral, HIV and psychopatological
variables predicting general sharing behavior
Results/predictors R2 Change F Beta t
General sharing behavior Step 1 .208 5.99***
Gender .206 2.34***
Education -.056 ns
Professional status .004 ns
With whom they live .317 3.57***
Years of drug use .126 ns
Step 2 .214 4.35***
Gender .229 2.48***
Education -.060 ns
Professional status .012 ns
With whom they live .306 3.28***
Years of drug use .135 ns
Transmission Knowledge .015 ns
Prevention Knowledge .083 ns
Step 3 (final model) .317 2.98***
Gender .140 ns
Education -.076 ns
Professional status -.044 ns
With whom they live .330 3.52***
Years of drug use .084 ns
Transmission Knowledge .078 ns
Prevention Knowledge .109 ns
Somatization .288 ns
Obsession-compulsion .315 ns
Interpersonal sensitivity -.138 ns
Depression .087 ns
Anxiety -.206 ns
Hostility .070 ns
Phobic anxiety .088 ns
Paranoid ideation -.147 ns
Psychoticism -.041 ns
R2=.317; adjusted R2=.210
Note. ***p<0.001, **p<0.01, *p<0.05.
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Results of the hierarchical linear regression analysis for the prediction of syringe sharing are
displayed in Table 3. The final model explains 42.4% of variance of syringe sharing [R²=.424,
F(16,103)=4.73, p<.001]. The analysis of individual predictors showed that gender (females), lower
educational level, living alone, high obsession-compulsion symptoms were the statistically significant
predictors of syringe sharing. Nevertheless, at step 1, only socio-demographic predictors explain
33.6% of the syringe sharing, and the addition of knowledge variables don’t improve significantly
the model (∆R2=.008, p>.05), neither does the inclusion of psychopathological symptoms (∆R2=.080,
p>.05).
Table 3
Hierarchical linear regression for sociodemographic, behavioral, HIV, and psychopatological
variables predicting syringe sharing
Results/predictors R2 Change F Beta t
Syringe sharing Step 1 .336 11.5***
Gender .288 -3.56***
Education -.281 -3.46***
Professional status -.032 ns
With whom they live .251 -3.09***
Years of drug use .107 ns
Step 2 .344 8.38***
Gender .260 -3.08***
Education -.280 -3.34***
Professional status -.042 ns
With whom they live .268 -3.14***
Years of drug use .097 ns
Transmission Knowledge .033 ns
Prevention Knowledge -.097 ns
Step 3 (final model) .424 4.73***
Gender .187 -2.11***
Education -.321 -3.81***
Professional status -.072 ns
With whom they live .271 -3.15***
Years of drug use .034 ns
Transmission Knowledge .053 ns
Prevention Knowledge -.094 ns
Somatization .116 ns
Obsession-compulsion .371 -2.42***
Interpersonal sensitivity .007 ns
Depression .257 ns
Anxiety -.028 ns
Hostility -.047 ns
Phobic anxiety -.159 ns
Paranoid ideation -.204 ns
Psychoticism -.161 ns
R2=.317; adjusted R2=.210
Note. ***p<0.001, **p<0.01, *p<0.05.
Considering the prediction of sharing other materials, all the analyzed predictors explain 32.2%
of the variance of this variable [R²=.322, F(16,103)=3.06, p<.001]. As we can see in Table 4, this
model shows that among individual statistically significant predictors, lower educational level,
living alone, and higher somatization were related with other materials shared in injecting drug
use. Socio-demographics explain 23.4% of the variance, and neither the addition of knowledge
variables in step 2 (∆R2=.003, p>.05), nor the psychopathological symptoms improve significantly
the final model (∆R2=.086, p>.05).
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Table 4
Hierarchical linear regression for sociodemographic, behavioral, HIV and psychopatological
variables predicting sharing other materials used in intravenous drug use
Results/predictors R2 Change F Beta t
Other materials sharing Step 1 .234 6.95***
Gender .221 -2.54**
Education -.177 -2.03**
Professional status -.090 ns
With whom they live .232 -2.66**
Years of drug use .131 ns
Step 2 .237 4.97***
Gender .203 -2.23**
Education -.178 ns
Professional status -.097 ns
With whom they live .245 -2.66**
Years of drug use .123 ns
Transmission Knowledge .030 ns
Prevention Knowledge -.062 ns
Step 3 (final model) .322 3.06***
Gender 185 ns
Education -.192 -2.10**
Professional status -.124 ns
With whom they live .208 -2.22**
Years of drug use .084 ns
Transmission Knowledge .034 ns
Prevention Knowledge -.019 ns
Somatization .398 -2.37**
Obsession-compulsion .014 ns
Interpersonal sensitivity .205 ns
Depression .171 ns
Anxiety -.181 ns
Hostility -.065 ns
Phobic anxiety -.057 ns
Paranoid ideation -.216 ns
Psychoticism -.036 ns
R2=.317; adjusted R2=.210
Note. ***p<0.001, **p<0.01, *p<0.05.
Discussion
Our findings show that three in each four participants were males, and had an average age of
34 years old, a result consistent with other community surveys and clinical samples in Portugal
(EMCCDA, 2012). The majority were single, unemployed, and reported a chronic use of illicit
substances starting in adolescence. Corroborating other authors findings on HIV risk behaviors
among IDUs (Disney et al., 2006; Kirdorf et al., 2004; Mackesy-Amiti et al., 2012), our results
showed a pattern of multiple substance abuse (e.g., tobacco, alcohol, cocaine, heroin, etc.), loss
of control of drug use and deviant behaviors – half of the sample had an overdose, some individuals
had been arrested and most of these shared materials while in prison. These results show the social
repercussions of drug addiction, and early age of drug use initiation suggests the need to design
primary prevention interventions beginning in adolescence.
Besides de social disintegration, drug addiction constitutes also a public health concern. In the
last decades, worldwide and also in Portugal (Barros, 2012; WHO, 2013), maybe due to awareness
of injecting harmful behaviors for HIV exposure, there has been a reduction of HIV among IDUs,
399
however, something is still missing. In our sample about one in each three persons were HIV
infected, and most of them believed that sharing materials in drug use was the main via of
transmission. This result shows how our sample is indeed an at risk group for HIV infection and
transmission, and for this reason, it is important to determine the main correlates of HIV-risk
sharing behaviors in order to design effective preventive interventions. Besides, other blood borne
infections were also found, as it is common in this at risk population, but in our sample the
comparative percentage with general statistics (EMCDDA, 2012; INSA, 2013) was substantially
inferior for HCV (35.8%), and superior for HIV (31.7%) and HBV (11.17%). 
Almost all the participants in our sample had greater adherence to HIV testing and this seems
to indicate that HIV testing campaigns are targeting this at risk group. Furthermore, they showed
accurate knowledge about HIV transmission and prevention, but for a significant part of the sample
sharing injecting materials still happens. These results did not corroborate the notion that the lack
of accurate information about HIV transmission and prevention increases the vulnerability to the
infection (Goncalez et al., 2010) or less HIV serostatus testing (Bertoni et al., 2011). In fact, almost
all the participants in the current study were tested for HIV, and 85% of them know that “they can
be infected with HIV by sharing syringes with someone with HIV”, but about a third shared syringes
or other materials, and half of them shares materials in general. This suggests that other factors,
besides HIV transmission and prevention knowledge, are involved in the adherence to HIV
preventive measures (e.g., safe injecting practices). Most of the IDUs in this sample had accurate
HIV transmission and prevention knowledge, nevertheless, behavioral change is not occurring for
some IDUs that are at risk for HIV infection and for that reason cognitive behavioral interventions
addressing specific skills and targeting HIV/AIDS risk behaviors are recommended. Additionally,
a great majority deemed HIV risk to be high in their communities but deemed their personal risk
to be zero or low. Since they have accurate HIV/AIDS knowledge we would expect that they
would perceive themselves to be more at risk for HIV, once they have risk behaviors (syringe
sharing and unprotected sex). Possibly, this lack of personal risk perception is interfering with the
adoption of precaution measures and the common strategy used in HIV interventions of raising
awareness of risk (Crisp et al., 1993; Tsui, Lau, Xiang, Gu, & Wang, 2012) should be integrated
in HIV prevention interventions. In the present study, risk perception and HIV transmission and
prevention knowledge were not significant predictors of sharing risk behaviors. 
Some studies reported that education about HIV transmission in IDUs is a necessary and
efficient way to reduce injecting risk behaviors (Aspinall et al., 2013; Go et al., 2013; Mackesy-
Amiti et al., 2013), but itself alone is not totally accepted as a sufficient vector on HIV prevention
(Madray & van Hulst, 2000; Palmateer, 2010; Sarkar et al., 1995). Furthermore, our results do
not corroborate other authors who defend the efficacy of NSP in reducing injecting risk behaviors
(Palmateer et al., 2010). Differently, our results seem to confirm Sarkar and col. (1995) results,
which defend that harmful behaviors among IDUs are not influenced by knowledge on HIV
transmission or HIV testing serostatus. Similar to our results, other evidence also shows that among
HIV infected individuals who inject drugs about 40% still share needles or do not use condoms
(Amirkhanian et al., 2011). Thus, it is a concern to understand the factors related with behavioral
change and with safe injecting practices, besides education. The factors related with the adherence
to HIV preventive programs among IDUs are not totally understood, and a multifactorial
perspective involving more than individual dimensions, such as public health facilities or legal
control of syringe and needles sharing, in order to a dissuasion of harmful behaviors on IDUs
(Beletsky et al., 2014; Chakrapani, Newman, Shunmugam, & Dubrow, 2011). Pragmatic strategies,
such as safe injecting practices are guiding public health policies in the reduction of harmful
consequences of injecting drugs, like HIV infection, should not be taken as the ultimate goal of
intervention, but rather the physical and mental treatment of these persons as well as the promotion
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of their social reintegration. Furthermore, primary prevention campaigns should fight against HIV
and also against drug addiction, either at the community level or targeting at-risk groups. 
Besides addiction, HIV serostatus, other comorbid physical and psychiatric diseases impair
IDUs quality of life. Also, psychiatric disorders comorbidity such as psychosis, mood disorders
(suicide and major depression) or personality disorders (Mackesy-Amiti et al., 2012) were
consensually an accepted factor related with more harmful injecting practices on IDUs (Buckley,
2006; Santucci, 2012). Scientific literature consistently reports that those who have dual diagnosis
have poor prognosis and non-adherence to treatment (Santucci, 2012). If the addiction could be a
method to face psychopathology and the sharing behaviors could be the easiest way to get drugs,
on the other way, the psychopathological symptoms could also increase the likelihood of drug use
along with greater sharing behavior due to devaluation of risk behaviors common in some
psychiatric disorders, and in our sample, in fact most of the participants recognized the risk in
their communities but not in themselves. At one hand, it seems consensual among authors that
people with a psychiatric disorder appear to be more vulnerable to HIV infection (Grassi, 1996;
Logan, Cole, & Leukefeld, 2002), and this could be due to the fact that HIV increases behavioral
disorganization and lowers the ability to self-control (Rabkin, McElhiney, & Ferrando, 2004; Stoff,
2004) and depressive symptoms (Norcini, 2013). Individuals with psychiatric disorders are more
predisposed to have sharing behaviors (Disney et al., 2006; Sarin, Singh, Samson, & Sweat, 2013).
So, we hypothesized that among IDUs, higher psychopathological symptoms could be the major
reason in the explanation of sharing, and our results showed a positive relationship, but, when
socio-demographics and HIV knowledge were controlled previously, only somatization and
obsession compulsion symptoms remained statistically significant. Somatization symptoms
predicted significantly more sharing of potentially infected syringes, possibly related with craving
or as a result of chronic diseases, and obsession compulsion symptoms can be an indicator of the
common urge for drug seeking in our sample, that put them at higher risk of sharing other materials
when injecting drugs.
Our results showed that among all the analyzed predictors of sharing (socio-demographic
variables, knowledge about HIV infection and psychopathological symptoms), gender (women)
and IDUs living alone are consistent predictors of sharing behaviors. This result seems to reflect
that, as a minority among IDUs, women seem to be confronted with even more challenges to cope
with drug addiction and social exclusion, and the lack of social support, making them more
vulnerable to HIV risk behaviors, as are harmful injecting practices. In fact, empirical evidence
shows that women have more depressive symptoms than men, particularly if they are both HIV
seropositive and inject drugs (Wisniewski et al., 2005). In our study, women constitute a vulnerable
group for HIV infection by sharing injecting materials, however, comorbid HIV infection was not
a controlled variable. Other socio-demographic variables such as lower educational status, living
alone, and long-term drug use also predicted sharing injecting materials, but surprisingly
knowledge about HIV did not.
Our results support the view that psychosocial and psychopathological factors seem to be
interrelated and explain harmful risk injecting practices among IDUs. In our understanding,
biopsychosocial framework on drug addiction (Gardner, 2011) provides an explanation for these
results. In part, the chronic use of drugs may have noxious effects on brain physiological regulation
mechanisms, namely on anti-reward systems (Gardner, 2011; Koob & Le Moal, 2008), resulting
in compulsion to drug seeking, high allostatic load and consequently more somatic symptoms.
Drug addiction is also erosive to psychosocial adaptation and results in more social discrimination
and exclusion, that is higher when drug users are simultaneously seropositive, increasing
psychological distress and more drug seeking to cope with this burden. To complexify the problem,
a third of the participants in our study also have HIV seropositive status and literature agrees on
neurobiological and psychosocial effects of HIV on brain and psychopathology, namely depression
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(Norcini, 2013), which in turn is associated with more risk behaviors. In our sample, depression
is significantly correlated with sharing but lacks its predictive power when other variables are
considered in the regression model. HIV status was not a controlled variable in the present study,
an aspect to be considered in future research.
In the current study causality and etiological aspects were not addressed themes, because of
methodological limitations of a cross-sectional study and correlation analysis. In future studies
longitudinal risk trajectories of IDUs, encompassing multifactorial aspects associated with drug
addiction and psychiatric disorders as well as their relation with HIV risk behaviors, should be
further understood. Some study limitations were already addressed. Nevertheless, caution should
be used when generalizing the results to other drug users. Also, we have to consider the limitations
of data based on self-report and the relatively small sample size. There is a problem in using self-
report questionnaire for assessing psychopathology among drug users because they might be under
the influence of substances when answering them and they also might not understand some of the
questions, leaving room for misreporting. Assessment by researchers/clinicians allows assessing
comorbid mental and substance-use disorders and allows better diagnostic decisions. Indeed,
several types of relationships between substance use and mental disorders are possible. Substance
use may be causing the psychopathology, substance use may be secondary to the psychopathology,
or the mental disorder and the substance-use problems may be coincidental and not related to each
other in one of the ways described above.
Despite these limitations, this study contains a number of findings that may contribute to HIV
prevention efforts in IDUs directing the attention to new target variables. Knowledge of HIV
transmission and prevention may not be sufficient to reduce IDUs’ harmful risk behavior without
improving personal risk perception, motivation, social support and mental health treatment.
In conclusion, this study provides evidence that reinforces the implementation of HIV
preventive interventions, articulating both individual and social structural dimensions in a systemic
integrated way. Our results did not corroborate health behavior theories (Janz & Becker, 1984;
Schwarzer, 1999). In spite of it, psychosocial factors and psychopathological symptoms, in
particular somatization and obsessive-compulsive symptoms seem to explain better sharing than
HIV knowledge and risk perception. Some support for socio-demographic variables was found,
such as female gender and those living alone need further attention in order to reduce HIV harmful
behaviors. In our opinion, biopsychosocial model of drug addiction (Gardner, 2011) provides a
good explanation for our findings, strengthening the interrelationship between physiological
aspects of drug addiction, social exclusion and psychological distress and high allostatic load. In
fact half of the participants suffer from chronic diseases, a third of them were infected with HIV
and/ or other infectious diseases, a result that shows that drug addiction constitutes a serious life-
threatening problem and encompasses negative social repercussions. The definition of main
predictors of HIV risk behaviors seems to indicate the need to focus more on gender issues and
on socially isolated individuals, and provide treatment to somatic and craving symptoms, in order
to reduce sharing.
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Apesar da introdução de programas de troca de agulhas e seringas (PTS), a partilha de seringas e de
outros materiais permanece comum entre os utilizadores de drogas injetáveis (UDIs) em todo o mundo.
Por esta razão, os UDIs estão em elevado risco de transmissão do VIH. Este artigo estuda os
determinantes psicossociais e psicopatológicos da partilha entre os UDIs. Compreender a relação entre
morbilidade psicológica, conhecimentos sobre o VIH, percepção de risco face ao VIH e
comportamentos de partilha é importante para desenvolver campanhas de contenção de partilha entre
os UDIs. Foram recrutados 120 homens (76.7%) e mulheres (23.3%) UDIs num serviço de tratamento
ambulatório público no norte de Portugal, cuja média de idade foi de 34 (dp=7.56). Os participantes
foram caracterizados ao nível das variáveis sócio-demográficas, clínicas e comportamentais, bem como
ao nível dos conhecimentos sobre a transmissão e prevenção do VIH, percepção de risco face ao VIH
e sintomas psicopatológicos. Quase todos os pacientes (95.8%) foram testados para VIH e 31.7%
testaram positivo. Metade tinha uma doença crónica (50.8%) e declarou envolver-se em
comportamentos de partilha (51.7%). A maioria possuía conhecimentos corretos sobre a transmissão
e prevenção do VIH. A grande maioria considera que o risco face ao VIH é elevado nas suas
comunidades (80.8%), mas considera o seu risco pessoal como nulo ou baixo (72.5%). A análise
estatística mostrou que as variáveis sócio-demográficas (sexo feminino, baixo nível de escolaridade,
viver sozinho) e os sintomas psicopatológicos (obsessão-compulsão e somatização) predizem a partilha.
Concluímos que o desenvolvimento e a implementação de campanhas para reduzir a partilha entre os
UDIs deve-se concentrar mais nas mulheres, nos UDIs que vivem sós, bem como na avaliação e
intervenção precoces nos distúrbios psicopatológicos.
Palavras-chave: Comportamento de risco injectável face ao VIH, Conhecimentos face ao VIH,
Percepção de risco face ao VIH, Psicopatologia, Utilizadores de drogas injetáveis (UDIs), Portugal.
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